GW Plastics (Royalton, Vt.) recently announced that it has expanded and upgraded its tooling facility, adding additive manufacturing technology.

The company has invested in medical 3D printing technology to help with conformal cooling and improve cycle times up to 30%.

“This additive manufacturing technology streamlines tool design, reducing the components needed to build a mold and the overall investment our customers need to make,” Timothy Holmes, VP of engineering at GW Plastics, said in a press release. “We are proud to offer this level of technology to our customers to ensure their products are being manufactured in the best mold possible.”

GW Plastics has invested over $2 million in its Vermont-based mold facility over the last 12 months to help support its R&D goals and expansion efforts. The company also recently acquired Avenue Mold Solutions in Ireland to expand its footprint into Europe.

“More importantly than just having advanced tooling capability, GW Plastics now has the global capacity to handle large-scale programs, including ultra-high-cavitation, multi-components and silicone mold-building for our multi-national customers,” Brenan Riehl, GW Plastics president and CEO, said. “With recent expansions of our tooling facilities in the U.S. and China and the acquisition of Avenue Mold Solutions in Ireland, GW Plastics now has both the expertise and infrastructure to give our customers the peace of mind that we can support their complex programs on three continents.”